Abiopharma

🔍 MCCALLISTER MICHAEL B (Director)

Company: AT&T INC. (T)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-29 | Code: H | nature_of_ownership: By Family Trust | shares_owned_after: 62,076.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-29 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 7,000.00
• Acquired 9,274 shares of Deferred Stock Units (Derivative)
  Date: 2026-05-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 165,354.97 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Deferred stock units acquired pursuant to the AT&T Inc. Non-Employee Director Stock and Deferral Plan. After the reporting person ceases to be a director, each unit is paid out in cash equal to the value of one share of AT&T common stock at times elected by the director.